Página 53 - RBHH34V5_FLIP_2

Versão HTML básica

366
Cunha KC, Oliveira MC, Gomes AC, Castro LP, Viana MB
Rev Bras Hematol Hemoter. 2012;34(5):361-6
xxx
20. Nelson M, Perkins SL, Dave BJ, Coccia PF, Bridge JA, Lyden ER, et al.
An increased frequency of 13q deletions detected by fluorescence in situ
hybridization and its impact on survival in children and adolescents with
Burkitt lymphoma: results from the Children’s Oncology Group study
CCG-5961. Br J Haematol. 2010;148(4):600-10.
21. Poirel HA, Cairo MS, Heerema NA, Swansbury J, Aupérin A, Launay
E, Sanger WG, Talley P, Perkins SL, Raphaël M, McCarthy K, Sposto
R, Gerrard M, Bernheim A, Patte C ; FAB/LMB 96 International
Study Committee. Specific cytogenetic abnormalities are associated
with a significantly inferior outcome in children and adolescents with
mature B-cell non-Hodgkin’s lymphoma: results of the FAB/LMB 96
international study. Leukemia. 2009;23(2):323-31.
22. Reiter A, Schrappe M, Tiemann M, Ludwig WD, Yakisan E,
Zimmermann M, et al. Improved treatment results in childhood
B-cell neoplasms with tailored intensification of therapy: A report
of the Berlin-Frankfurt-Munster Group Trial NHL-BFM 90. Blood.
1999;94(10):3294-306.
23. Magrath I, Lee YJ, Anderson T, Henle W, Ziegler J, Simon R, et al.
Prognostic factors in Burkitt’s lymphoma: importance of total tumor
burden. Cancer. 1980;45(6):1507-15.
24. Buyukpamukçu M, Varan A, Aydin B, Kale G, Akata D, Yalçin B, et al.
Renal involvement of non-Hodgkin’s lymphoma and its prognostic effect
in childhood. Nephron Clin Pract. 2005;100(3):c86-91.
25. Harif M, Barsaoui S, Benchekroun S, Bouhas R, Doumbé P, Khattab M,
et al. Treatment of B-cell lymphoma with LMB modified protocols in
Africa -report of the French-African Pediatric Oncology Group (GFAOP).
Pediatr Blood Cancer. 2008;50(6):1138-42. Comment in: Pediatr Blood
Cancer. 2008;50(6):1125-6.
26. Kazembe P, Hesseling PB, Griffin BE, Lampert I, Wessels G. Long
term survival of children with Burkitt lymphoma in Malawi after
cyclophosphamide monotherapy. Med Pediatr Oncol. 2003;40(1):23-5.
27. Acquatella G, Insausti CL, García R, Gómez R, Hernández M, Carneiro
M, et al. Outcome of children with B cell lymphoma in Venezuela with
the LMB-89 protocol. Pediatr Blood Cancer. 2004;43(5):580-6.
28. Moleti ML,Al-Hadad SA,Al-Jadiry MF,Al-DarrajiAF,Al-Saeed RM, De
Vellis A, et al. Treatment of children with B-cell non-Hodgkin lymphoma
in a low-income country. Pediatr Blood Cancer. 2011;56(4):560-7.
29. Naresh KN, Advani S, Adde M, Aziz Z, Banavali S, Bhatia K, et al.
Report of an International Network of Cancer Treatment and Research
workshop on non-Hodgkin’s lymphoma in developing countries. Blood
Cells Mol Dis. 2004;33(3):330-7.
30. Hochberg J, Cairo MS. Insight into the biology and treatment of pediatric
lymphomas: Clues from international studies. Pediatr Blood Cancer.
2009;52(2):153-4. Comment in: Pediatr Blood Cancer
.
2009;52(2):182-5.